C
BMRN icon

Covestor’s BioMarin Pharmaceuticals BMRN Stock Holding History

Covestor’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Sell
1,217
-856
-41% -$46.9K 0.04% 581
2026
Q1 		$117K Sell
2,073
-3,618
-64% -$211K 0.08% 229
2025
Q4 		$338K Buy
5,691
+1,276
+29% +$69.5K 0.18% 76
2025
Q3 		$239K Buy
4,415
+2,069
+88% +$118K 0.13% 148
2025
Q2 		$129K Buy
2,346
+916
+64% +$53.9K 0.08% 405
2025
Q1 		$101K Buy
1,430
+152
+12% +$10.2K 0.07% 481
2024
Q4 		$84K Buy
1,278
+248
+24% +$16.6K 0.05% 619
2024
Q3 		$72K Buy
1,030
+794
+336% +$66.4K 0.05% 707
2024
Q2 		$19K Sell
236
-393
-62% -$32.7K 0.01% 1213
2024
Q1 		$55K Sell
629
-34
-5% -$3.04K 0.03% 845
2023
Q4 		$64K Sell
663
-104
-14% -$9.2K 0.04% 740
2023
Q3 		$68K Buy
767
+95
+14% +$8.45K 0.05% 624
2023
Q2 		$58K Sell
672
-1
-0.1% -$94 0.04% 717
2023
Q1 		$66K Buy
673
+336
+100% +$34.8K 0.06% 591
2022
Q4 		$35K Buy
337
+169
+101% +$15.9K 0.03% 864
2022
Q3 		$14K Sell
168
-1
-0.6% -$89 0.01% 1112
2022
Q2 		$14K Sell
169
-4
-2% -$318 0.01% 1079
2022
Q1 		$13K Buy
173
+73
+73% +$6.11K 0.01% 1209
2021
Q4 		$9K Buy
+100
New +$8.25K 0.01% 1044

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Covestor's BMRN Position: Q2 2026 in Review

Covestor reduced its BioMarin Pharmaceuticals (BMRN) stake by 41% in Q2 2026, selling an estimated $46.9K and leaving 1,217 shares worth $70K. The position accounts for 0.04% of the portfolio, ranked #581.

Covestor first reported a position in BMRN in Q4 2021 and has held it in 19 quarters since. The position peaked at $338K in Q4 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Covestor held 1,217 shares of BioMarin Pharmaceuticals worth $70K as of Q2 2026.
  • Covestor sold 856 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $46.9K.
  • BioMarin Pharmaceuticals made up 0.04% of Covestor's portfolio in Q2 2026, its #581 holding.
  • Covestor first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's BioMarin Pharmaceuticals position peaked at $338K in Q4 2025.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.